Lantheus Holdings Inc logo

LNTH

Lantheus Holdings Inc

$82.4

Earnings Summary

Revenue
$223.72Mn
Net Profits
$43.06Mn
Net Profit Margins
19.25%
PE Ratio
197.96

Highlights

Revenue:

Lantheus Holdings Inc’s revenue jumped 121.37% since last year same period to $223.72Mn in the Q2 2022. On a quarterly growth basis, Lantheus Holdings Inc has generated 7.11% jump in its revenue since last 3-months.

Net Profits:

Lantheus Holdings Inc’s net profit jumped 261.53% since last year same period to $43.06Mn in the Q2 2022. On a quarterly growth basis, Lantheus Holdings Inc has generated 0.22% jump in its net profits since last 3-months.

Net Profit Margins:

Lantheus Holdings Inc’s net profit margin jumped 172.97% since last year same period to 19.25% in the Q2 2022. On a quarterly growth basis, Lantheus Holdings Inc has generated -6.43% fall in its net profit margins since last 3-months.

PE Ratio:

Lantheus Holdings Inc’s price-to-earnings ratio after this Q2 2022 earnings stands at 197.96.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Lantheus Holdings Inc post its latest quarter earnings

EPS Estimate Current Quarter
0.7
EPS Estimate Current Year
0.7

Highlights

EPS Estimate Current Quarter:

Lantheus Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at 0.7 - a 52.17% jump from last quarter’s estimates.

EPS Estimate Current Year:

Lantheus Holdings Inc’s earning per share (EPS) estimates for the current year stand at 0.7.

Key Ratios

Key ratios of the Lantheus Holdings Inc post its Q2 2022 earnings

Return on Assets (ROA)
0.1
Return on Equity (ROE)
0.06
Dividend Per Share (DPS)
0

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Lantheus Holdings Inc’s return on assets (ROA) stands at 0.1.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Lantheus Holdings Inc’s return on equity (ROE) stands at 0.06.

Dividend Per Share (DPS):

Lantheus Holdings Inc declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-04-29
0.46
0.97
110.87%

Company Information

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow™ serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.

Organisation
Lantheus Holdings Inc
Headquarters
North Billerica, Massachusetts, US
Employees
595
Industry
Health Technology
CEO
Mary Heino